Satiety and Alcohol Challenge
SatTAC
Effect of a Dietary Supplement on Satiety and Acute Responses to Laboratory Alcohol Challenge
1 other identifier
interventional
64
1 country
1
Brief Summary
The goal of this pilot study is to identify the role of satiety on responses to alcohol drinking using human subject laboratory methods. Satiety will be manipulated over two sessions using a dietary supplement (fiber+green tea) or a calorically matched placebo. Responses to an acute alcohol challenge are measured.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2024
CompletedFirst Posted
Study publicly available on registry
August 29, 2024
CompletedStudy Start
First participant enrolled
September 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 9, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 9, 2025
CompletedResults Posted
Study results publicly available
December 5, 2025
CompletedDecember 5, 2025
August 1, 2025
7 months
August 26, 2024
November 20, 2025
November 20, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Alcohol Specific Satiety Score
The Alcohol-specific Satiety Questionnaire is a 16-item instrument designed to measure satiety to alcohol's effects. Ratings are made from Not at all; 0 to Extremely; 10, yielding total scores from 0 to 160 with higher values representing greater alcohol-specific satiety.
baseline to 60 minutes
Secondary Outcomes (5)
Change in Positive Affect Based on Subjective Effects of Alcohol Scale Score
baseline to 60 minutes
Change in Subjective Stimulation (Biphasic Alcohol Effects Scale)
baseline to 60 minutes
Change in Attention Bias to Alcohol Score
30 minutes after alcohol administration
Change in Alcohol Demand Score
baseline to 60 minutes
Change in Alcohol Urge Questionnaire Score
baseline to 60 minutes
Study Arms (2)
dietary supplement, then placebo
EXPERIMENTALParticipants receive a dietary supplement at the first study session (10g Fibersol®-2 mixed with water and aspartame sweetener + 725mg decaffeinated green tea extract capsule), and then the next study session they receive the placebo supplement (Aspartame sweetener mixed with water + aspartame capsule). Participants will also receive a drink containing alcohol (vodka + cranberry mixer) on both sessions.
placebo, then dietary supplement
EXPERIMENTALParticipants receive a placebo supplement at the first study session (Aspartame sweetener mixed with water + aspartame capsule), then the next session they receive the dietary supplement (10g Fibersol®-2 mixed with water and aspartame sweetener + 725mg decaffeinated green tea extract capsule). Participants will also receive a drink containing alcohol (vodka + cranberry mixer) on both sessions.
Interventions
Aspartame sweetener mixed with water + aspartame capsule
10g fiber + 750mg green tea supplement will be administered at experimental arm
alcohol administered up to a target BAC 0.06g/dL during lab sessions
Eligibility Criteria
You may qualify if:
- Age 21-45
- Meeting NIAAA criteria for current at-risk drinking (i.e., \>7/14 drinks in one week for women/men, with at least one episodes of 4+/5+ drinks in the past 30 days)
- Willingness to complete laboratory sessions involving blood draws and alcohol administration
- Ability to communicate and read in English
- Body mass index (BMI) of 21 - 30 kg/m\^2
You may not qualify if:
- Meets past-year criteria for severe Alcohol Use Disorder (\>7 of 11 symptoms endorsed) or AUDIT score of 20+
- Meeting past-year criteria for a substance use disorder (with the exception of alcohol, tobacco or mild cannabis use disorder)
- Current engagement in alcohol treatments, or currently engaged in intentional efforts to quit alcohol use
- Current use of weight control medications
- Lifetime diagnosis of severe mental illness (including schizophrenia and bipolar disorder)
- History of suicide attempt, or psychiatric hospitalization in the last 6 months
- History of diabetes
- Medical conditions or medications for which alcohol is contraindicated
- Pregnant, nursing, or trying to become pregnant
- Plans to travel during the duration of study participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of North Carolina
Chapel Hill, North Carolina, 27599, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Michael Bremmer, PhD
- Organization
- University of North Carolina at Chapel Hill
Study Officials
- PRINCIPAL INVESTIGATOR
Jimikaye Courtney, PhD
University of North Carolina, Chapel Hill
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- participant will be blinded to the session order in which they receive either the dietary supplements (fiber and green tea) or a placebo.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2024
First Posted
August 29, 2024
Study Start
September 3, 2024
Primary Completion
April 9, 2025
Study Completion
April 9, 2025
Last Updated
December 5, 2025
Results First Posted
December 5, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- beginning 9 and continuing for 36 months following publication
- Access Criteria
- Investigator has approved IRB, IEC, or REB and an executed data use/sharing agreement with UNC.
Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.